Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
37.48
-6.01 (-13.82%)
At close: May 8, 2026, 4:00 PM EDT
37.46
-0.02 (-0.07%)
After-hours: May 8, 2026, 7:36 PM EDT
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 594 employees as of December 31, 2025. The number of employees increased by 157 or 35.93% compared to the previous year.
Employees
594
Change (1Y)
157
Growth (1Y)
35.93%
Revenue / Employee
$30,419
Profits / Employee
-$835,670
Market Cap
3.95B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 594 | 157 | 35.93% | 594 | 0 |
| Dec 31, 2024 | 437 | 147 | 50.69% | 437 | 0 |
| Dec 31, 2023 | 290 | 80 | 38.10% | 290 | 0 |
| Dec 31, 2022 | 210 | 67 | 46.85% | 210 | 0 |
| Dec 31, 2021 | 143 | 50 | 53.76% | 143 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Travere Therapeutics | 497 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
| NewAmsterdam Pharma Company | 100 |
| Oruka Therapeutics | 68 |
CRNX News
- 1 day ago - Crinetics price target lowered to $95 from $97 at Citizens - TheFly
- 1 day ago - Crinetics Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Crinetics price target raised to $97 from $96 at Citizens - TheFly
- 11 days ago - Crinetics’ Palsonify approved by European Commission for acromegaly - TheFly
- 11 days ago - Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewsWire
- 6 weeks ago - Crinetics submits Palsonify marketing authorization application to ANVISA - TheFly